Obinutuzumab exposure during early twin pregnancy in antisynthetase syndrome with interstitial lung disease.

Gazyva (obinutuzumab) - Roche, Biogen

Obinutuzumab exposure during early twin pregnancy in antisynthetase syndrome with interstitial lung disease. (PubMed, EULAR Rheumatol Open) - Oct 11, 2026 - No abstract available
Journal • Interstitial Lung Disease • Pulmonary Disease • Rare Diseases • Respiratory Diseases

http://www.ncbi.nlm.nih.gov/pubmed/42857247

Ben Parker; Ellen Bruce; Kim MacLeod; Sarah Dyball

Oct 11, 2026